Lincoln Pharmaceuticals Limited (BOM:531633)
592.40
-0.40 (-0.07%)
At close: Apr 16, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 11.87 billion as of April 16, 2026. Its market cap has increased by 6.26% in one year.
Market Cap
11.87B
Enterprise Value
9.56B
Revenue
6.52B
Ranking
n/a
PE Ratio
13.52
Stock Price
592.40
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 11.87B, an increase of 8,448.03%. That is a compound annual growth rate of 22.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 11.87B | 22.68% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 16.06B |
| Amrutanjan Health Care | 15.57B |
| Shukra Pharmaceuticals | 15.48B |
| Venus Remedies | 13.89B |
| TTK Healthcare | 12.59B |
| Fermenta Biotech | 9.47B |
| Wanbury | 9.09B |
| Fredun Pharmaceuticals | 8.70B |